Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic

AIDS Research and Human Retroviruses

Volumn 19, Issue 7, 2003, Pages 551-560

  Bégaud, Evelyne ^a   Barré Sinoussi, Françoise ^b   Pancino, Gianfranco ^c   Feindirongai, Gilbert ^a   Versmisse, Pierre ^b   Ipero, Julienne ^a   Léal, Josiane ^a   Germani, Yves ^a   Morvan, Jacques ^a   Fleury, Hervé ^c   Müller Trutwin, Michaela ^b  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR GPR15; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CENTRAL AFRICA; CLINICAL ARTICLE; CLINICAL TRIAL; DEATH; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; SURVIVAL TIME; VIRUS ISOLATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMEBIASIS; CAUSE OF DEATH; CENTRAL AFRICAN REPUBLIC; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTESTINAL DISEASES, PARASITIC; LONGITUDINAL STUDIES; MALE; MILITARY PERSONNEL; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HIV; RECEPTORS, PEPTIDE; RECEPTORS, VIRUS; VIRAL LOAD; VIREMIA;

EID: 0042368609     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203322230914     Document Type: Article

References (48)

1. Berger EA, Murphy PM, Farber JM: Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
2. Zhang L, He T, Huang Y, et al.: Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1. J Virol 1998;72:9307-9312.
3. Alkhatib G, Combardiere C, Broder CC, et al.: CC CKR5: a RANTES, MIP-1alpha,MIP-1beta receptor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
4. Deng H, Liu R, Ellmeier W, et al.: Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-666.
5. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
6. Feng Y, Broder CC, Kennedy PE, et al.: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain. G-protein coupled receptor. Science 1996;272:872-877.
7. Zhu T, Mo H, Wang N, et al.: Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1179-1181.
8. Schuitemaker H, Koot M, Kootstra NA, et al.: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992;66:1354-1360.
9. Connor RI, Sheridan KE, Ceradini D, et al.: Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-628.
10. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-688.
11. Scarlatti G, Tresoldi E, Bjorndal A, et al.: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997;3:1259-1265.
12. Yu XF, Wang Z, Vlahov D, et al.: Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users. J Infect Dis 1998;178:388-396.
13. Glushakova S, Grivel JC, Fitzgerald W, et al.: Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat Med 1998;4:346-349.
14. Schramm B, Penn ML, Palacios EH, et al.: Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol 2000;74:9594-9600.
15. Grivel JC, Penn ML, Eckstein DA, et al.: Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol 2000;74:5347-5351.
16. Kreisberg JF, Kwa D, Schramm B, et al.: Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol 2001;75:8842-8847
17. Xiao L, Rudolph DL, Owen SM, et al.: Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998;12:F137-143.
18. Alkhatib G, Liao F, Berger EA, et al.: A new SIV co-receptor, STRL33. Nature 1997;388:238.
19. Deng H, Unutmaz D, KewalRamani VN, et al.: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
20. Farzan M, Choe H, Martin K, et al.: Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 1997;186:405-411.
21. Liao F, Alkhatib G, Peden KW, et al.: STRL33. A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997;185:2015-2023.
22. Edinger AL, Hoffman TL, Sharron M, et al.: Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998;249:367-378.
23. Pohlmann S, Krumbiegel M, Kirchhoff F: Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1. J Gen Virol 1999;80:1241-1251.
24. Tscheming-Casper C, Vodros D, Menu E, et al.: Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 2000;24:1-9.
25. Morgan D, Maude GH, Malamba SS, et al: HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997;350:245-250.
26. Morgan D, Ross A, Mayanja B, et al.: Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS 1998;12:591-596.
27. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al.: Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995;171:686-689.
28. Bwayo JJ, Nagelkerke NJ, Moses S, et al.: Comparison of the declines in CD4 counts in HlV-1-seropositive female sex workers and women from the general populatibn in Nairobi, Kenya. J Acquit Immune Defic Syndr Hum Retrovirol 1995;10:457-461.
29. Muller-Trutwin MC, Chaix ML, Letourneur F, et al.: Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr Hum Retrovirol 1992;21:164-171.
30. Jason J, Lui KJ, Ragni MV, et al.: Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA 1989;261:725-727.
31. Phair J, Jacobson L, Detels R, et al.: Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquit Immune Defic Syndr Hum Retrovirol 1992;5:490-496.
32. Phair JP: Determinants of the natural history of human immunodeficiency virus type 1 infection. J Infect Dis 1999;179:S384-386.
33. Rutherford GW, Lifson AR, Hessol NA, et al.: Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11-year follow-up study. BMJ 1990;301:1183-1188.
34. Lyles RH, Munoz A, Yamashita TE, et al.: Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multi-center AIDS Cohort Study. J Infect Dis 2000;181:872-880.
35. Whittle H, Morris J, Todd J, et al.: HIV-2-infected patients survive longer than HIV-1-infected patients. AIDS 1994;8:1617-1620.
36. Salinari RK, Filippo C, Claudio C: Preliminary survival analysis of AIDS data from Goma, Zaire. Trop Doct 1990;20:169-170.
37. Lucas SB, Hounnou A, Peacock C, et al.: The mortality and pathology of HIV infection in a west African city. AIDS 1993;7:1569-1579.
38. Bentwich Z, Kalinkovich A, Weisman Z: Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-191.
39. Grant AD, Djomand G, De Cock KM: Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 1997;11:S43-54.
40. Grant AD, Djomand G, Smets P, et al.: Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'Ivoire. AIDS 1997;11:1357-1364.
41. Yu XF, Wang Z, Beyrer C, et al.: Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J Virol 1995;69:4649-4655.
42. Li S, Juarez J, Alali M, et al.: Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates. J Virol 1999;73:9741-9755.
43. Chan SY, Speck RF, Power C, et al.: V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol 1999;73:2350-2358.
44. Bjorndal A, Deng H, Jansson M, et al.: Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 1997;71:7478-7487.
45. Xiao L, Owen SM, Goldman I, et al.: CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998;240:83-92.
46. Zhang YJ, Dragic T, Cao Y, et al.: Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol 1998;72:9337-9344.
47. Bleul CC, Wu L, Hoxie JA, et al.: The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
48. van Rij RP, Blaak H, Visser JA, et al.: Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest 2000;106:1569.